EIF4G2 was also found to act as a target of several miRNAs, including miR-379 in osteosarcoma [37], miR-139-5p in myeloid leukemia [38], and miR-520c-3p in diffuse large B-cell lymphoma [39]. This evidence concerns the gene EIF4G2 and myeloid leukemia.